Pfizer to offload 540 million shares in shocking Haleon sale—What does this mean for the healthcare giant?
In a blockbuster move set to shake up the market, Pfizer has announced its plan to sell approximately 540 million ordinary shares in Haleon, one ... Read More
Haleon to sell non-US nicotine replacement therapy portfolio to Dr. Reddy’s Laboratories
Haleon plc, a prominent player in the global healthcare market, has reached an agreement to sell its nicotine replacement therapy (NRT) business outside of the ... Read More
Suave Brands to expand portfolio with ChapStick lip balm brand acquisition
Yellow Wood Partners, a Boston-based private equity firm recognized for its strategic investments in consumer brands, has announced a significant development in the personal care ... Read More